Pain relief procedures before high-dose-rate brachytherapy for non-surgical treatment of cervix cancer

Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still an important public health problem in most developing countries. No significant difference is found in the literature between intracavitary high-dose-rate (HDR) and low-dose-rate (LDR) brachytherapy, when conside...

Full description

Saved in:
Bibliographic Details
Published in:Journal of contemporary brachytherapy 2018-12, Vol.10 (6), p.567-569
Main Author: Pellizzon, Antonio Cássio Assis
Format: Article
Language:English
Subjects:
brachytherapy
Cancer
Cervical cancer
cervix cancer
Developing countries
Dosage
Gynecological cancer
intracavitary
LDCs
Pain
Pain management
pain relief
Public health
Radiation therapy
Review Paper
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still an important public health problem in most developing countries. No significant difference is found in the literature between intracavitary high-dose-rate (HDR) and low-dose-rate (LDR) brachytherapy, when considering overall, disease specific, and recurrence-free survivals. Cervical dilatation is mandatory for the insertion of intra-uterine tandems for CC intracavitary brachytherapy. Pain and discomfort may eventually be the limiting factors of the procedure, sometimes leading to unsatisfactory results in terms of adequate position of the applicator set. In this paper, we critically reviewed the current sedation and anesthetic options for comfort and safety procedures when performing intracavitary brachytherapy.
ISSN:1689-832X
2081-2841
DOI:10.5114/jcb.2018.81027